Down syndrome - New prospects for an ancient disorder

JAMA

Volumn 303, Issue 24, 2010, Pages 2525-2526

  Einfeld, Stewart L ^a   Brown, Rebecca ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MEMANTINE;

ALZHEIMER DISEASE; CHROMOSOME 21; DOWN SYNDROME; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; NONHUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; TRISOMY;

EID: 77953868415     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.842     Document Type: Note

References (10)

1. Shin M, Besser LM, Kucik JE, Lu C, Siffel C, Correa A; Congenital Anomaly Multistate Prevalence and Survival Collaborative. Prevalence of Down syndrome among children and adolescents in 10 regions of the United States. Pediatrics. 2009;124(6):1565-1571.
2. Richard F, Dutrillaux B. Origin of human chromosome 21 and its consequences: a 50-million-year-old story. Chromosome Res. 1998;6(4):263-268.
3. Down JLH. Observations on an ethnic classification of idiots. London Hosp Rep. 1866;3:259-262.
4. Lejeune J, Gautier M, Turpin R. Study of somatic chromosomes from 9 mongoloid children [in French]. C R Hebd Seances Acad Sci. 1959;248(11):1721- 1722.
5. Delabar JM, Theophile D, Rahmani Z, et al. Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur J Hum Genet. 1993;1(2):114-124.
6. Wisniewski KE, Wisniewski HM, Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol. 1985;17(3):278-282.
7. Rachidi M, Lopes C. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways. Eur J Paediatr Neurol. 2008;12(3):168-182. (Pubitemid 351545848)
8. Guedj F, SébriéC, Rivals I, et al. Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A. PLoS One. 2009;4(2):e4606.
9. Costa ACS, Scott-McKean JJ, Stasko MR. Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test. Neuropsychopharmacology. 2008;33(7):1624-1632.
10. Baek KH, Zaslavsky A, Lynch RC, et al. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature. 2009;459(7250):1126-1130.